Skip to main content
. 2022 Sep 9;15(9):1128. doi: 10.3390/ph15091128

Figure 3.

Figure 3

Transmission Electron Microscopy Images of Formulation 1 and Formulation 2. (A): Formulation 1 contained 60% CPD and HPV16 VLP alone (prior to mixing with adjuvant MPs). (B): Formulation 2 contained 20% CPD, 5% vaccine and adjuvant loading HPV16 VLP, MPL and alum.